Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

George Liang King, M.D.

Concepts

This page shows the publications George King has written about Diabetic Angiopathies.
Connection Strength

4.882
  1. Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture. Diabetes. 2016 06; 65(6):1462-71.
    View in: PubMed
    Score: 0.425
  2. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res. 2010 Apr 30; 106(8):1319-31.
    View in: PubMed
    Score: 0.279
  3. Kidney complications: factors that protect the diabetic vasculature. Nat Med. 2010 Jan; 16(1):40-1.
    View in: PubMed
    Score: 0.272
  4. More sugar, less blood vessels: another piece in the puzzle of increased cardiovascular risk in diabetes. Arterioscler Thromb Vasc Biol. 2008 Apr; 28(4):608-10.
    View in: PubMed
    Score: 0.241
  5. Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care. 2007 Aug; 30(8):1995-7.
    View in: PubMed
    Score: 0.227
  6. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res. 2007 Jun; 55(6):498-510.
    View in: PubMed
    Score: 0.227
  7. Can protein kinase C beta-selective inhibitor, ruboxistaurin, stop vascular complications in diabetic patients? Diabetes Care. 2005 Nov; 28(11):2803-5.
    View in: PubMed
    Score: 0.204
  8. Molecular targets of diabetic cardiovascular complications. Curr Drug Targets. 2005 Jun; 6(4):487-94.
    View in: PubMed
    Score: 0.198
  9. Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications. Curr Diab Rep. 2005 Apr; 5(2):91-7.
    View in: PubMed
    Score: 0.196
  10. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol. 2005 Mar; 25(3):487-96.
    View in: PubMed
    Score: 0.193
  11. Microvascular complications of diabetes. Endocrinol Metab Clin North Am. 2004 Mar; 33(1):215-38, xi-xii.
    View in: PubMed
    Score: 0.182
  12. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA. 2002 Nov 27; 288(20):2579-88.
    View in: PubMed
    Score: 0.167
  13. Protein kinase C and the development of diabetic vascular complications. Diabet Med. 2001 Dec; 18(12):945-59.
    View in: PubMed
    Score: 0.156
  14. High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes. Diabetes Care. 2020 01; 43(1):178-186.
    View in: PubMed
    Score: 0.134
  15. Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications? Diabetes Res Clin Pract. 1999 Sep; 45(2-3):169-82.
    View in: PubMed
    Score: 0.133
  16. Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes. Diabetes Care. 1999 Apr; 22 Suppl 3:C31-7.
    View in: PubMed
    Score: 0.129
  17. The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Perit Dial Int. 1999; 19 Suppl 2:S222-7.
    View in: PubMed
    Score: 0.127
  18. Cognitive Function Deficits Associated With Long-Duration Type 1 Diabetes and Vascular Complications. Diabetes Care. 2018 08; 41(8):1749-1756.
    View in: PubMed
    Score: 0.122
  19. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med (Berl). 1998 Jan; 76(1):21-31.
    View in: PubMed
    Score: 0.119
  20. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab. 2017 12 01; 102(12):4343-4410.
    View in: PubMed
    Score: 0.118
  21. Association of Glycemic Control With Reduced Risk for Large-Vessel Disease After More Than 50 Years of Type 1 Diabetes. J Clin Endocrinol Metab. 2017 10 01; 102(10):3704-3711.
    View in: PubMed
    Score: 0.117
  22. The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes. Ann Med. 1996 Oct; 28(5):427-32.
    View in: PubMed
    Score: 0.109
  23. Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes. 1996 Jul; 45 Suppl 3:S105-8.
    View in: PubMed
    Score: 0.107
  24. The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am. 1996 Jun; 25(2):255-70.
    View in: PubMed
    Score: 0.106
  25. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science. 1996 May 03; 272(5262):728-31.
    View in: PubMed
    Score: 0.106
  26. Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med. 1994; 45:179-88.
    View in: PubMed
    Score: 0.090
  27. A cell biology approach to the study of diabetic vascular complications. J Diabet Complications. 1991 Apr-Sep; 5(2-3):56-7.
    View in: PubMed
    Score: 0.074
  28. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A. 1989 07; 86(13):5141-5.
    View in: PubMed
    Score: 0.066
  29. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab. 2007 Jan; 3(1):46-56.
    View in: PubMed
    Score: 0.055
  30. Cell biology as an approach to the study of the vascular complications of diabetes. Metabolism. 1985 Dec; 34(12 Suppl 1):17-22.
    View in: PubMed
    Score: 0.051
  31. Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels. J Clin Invest. 1983 Apr; 71(4):974-9.
    View in: PubMed
    Score: 0.043
  32. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation. 2002 May 07; 105(18):e138-43.
    View in: PubMed
    Score: 0.040
  33. Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg. 2001 Mar; 33(3):601-7.
    View in: PubMed
    Score: 0.037
  34. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999 Sep; 48(9):1856-62.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.